President
CurrentAdvisory & Due Diligence Services for Healthcare PE/VC as well as Product Strategy, Product Development, Technology Strategy and Cyber Security Services for startups and PE backed healthcare and SaaS firms. Seed Stage Investing in Healthcare Tech Startups.Select Assignments:- Telehealth Venture Creation - stealth mode- Engaged by a $2.5B PE backed PBM, Drug Cost Management, Pharmacy Technology and Services firm to help with Product and Technology strategy in 2022.- Engaged by Walmart to develop an Integrated Specialty Pharmacy offering using broad Walmart Health capabilities, with a focus on providing Best in Class Patient Engagement and Prescriber Integration, supported by Digital Solutions in 2022.- Engaged by Avita (PE backed firm) in 2019 to help acquire and integrate five regional HIV / 340B Pharmacy entities and develop the nation’s number one HIV Therapy Management + 340B Administration Platform. The two year "Remediate - Integrate - Differentiate" engagement included:⠀⠀» Tech/Product Due Diligence, remediation and integration of all five acquired entities⠀⠀» Identification and assessment of Target Market, Key Personas and Unmet Needs⠀⠀» Development of differentiated, market facing technology solutions to serve the most underprivileged and underserved patients in the country, and the clinics that take care of them⠀⠀» Leading technology, product development and information security efforts⠀⠀» Selection and adoption of modern Operating Systems as well as Cloud, SDWAN, Edge Security, MSP and MSSP services.- White Label Integrated Telehealth + Pharmacy Platform Developed (as a JV) in 2019.- 340B + Drug Spend Management SaaS JV in 2015, exit in 2018.